HIF1A and lung cancer: One year later, Zheng and co-workers reported a microarray lung cancer model designed to study liver metastasis in hypoxic conditions, focusing on the therapeutic effects of HIF-1 inhibitors on invasion (Zheng et al., 2021; Zhu et al., 2023).